Pfizer's IBRANCE Receives Approval in China
Caption Pfizer's IBRANCE Receives Approval in China
Source Pfizer
Other pictures
Download
Related Press Releases Links 辉瑞乳腺癌治疗突破性创新药爱博新(R)(哌柏西利)在中国获批
輝瑞乳腺癌治療突破性創新藥愛博新(R)(呱柏西利)在中國獲批
Pfizer's Breakthrough Innovative Drug IBRANCE(R) (palbociclib) Receives Approval in China